Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

Disc Medicine Eyes Mid-2026 Bitopertin Approval as EPP Trial Demand Surges

Disc Medicine (NASDAQ:IRON) Chief Executive Officer John Quisel said patient demand for the company’s bitopertin program in erythropoietic protoporphyria, or EPP, remains strong after the company enrolled 183 patients in the APOLLO confirmatory study, above its original target of 150. Speaking at a

JOYY Q1 Earnings Call Highlights

JOYY (NASDAQ:YY) reported its strongest year-over-year revenue growth in recent years in the first quarter of 2026, as its social entertainment business returned to growth and newer businesses in advertising technology and commerce continued to scale. The company said total net revenue rose 12.4% y

Opus Genetics Touts Retinal Gene Therapy Pipeline, September BEST1 Data Catalyst

Opus Genetics (NASDAQ:IRD) is advancing a portfolio of gene therapies for inherited retinal diseases, with two programs already in the clinic and three more expected to enter clinical testing within the next 12 months, President Dr. Ben Yerxa said during a fireside chat at RBC Capital Markets’ 2026

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

PPDAI Group Q1 Earnings Call Highlights

PPDAI Group (NYSE:FINV), referred to on the call as FinVolution Group, reported a steady first quarter of 2026 as management highlighted improving credit trends in China, continued overseas growth and a new reporting structure designed to give investors more visibility into its international operati

Ionis Pharmaceuticals Eyes Big Year With TRYNGOLZA Decision, 5 Phase 3 Readouts

Ionis Pharmaceuticals (NASDAQ:IONS) highlighted a busy slate of regulatory decisions, clinical readouts and partnered programs during a presentation at RBC Capital Markets’ Global Healthcare Conference, with Chief Development Officer Holly Kordasiewicz saying the company is moving from recent launch

Intel CEO Touts Balance Sheet Progress, Foundry Gains and AI CPU Demand

Intel (NASDAQ:INTC) Chief Executive Officer Lip-Bu Tan said the company has made progress on strengthening its balance sheet, improving execution and rebuilding customer trust, while acknowledging that its foundry ambitions remain a long-term effort. Speaking with J.P. Morgan semiconductor analyst

Intapp Says AI Is Driving Demand as Celeste Tackles Compliance Risks

Intapp (NASDAQ:INTA) executives said artificial intelligence is emerging as a demand driver for the company’s professional-services software platform, particularly as large law firms, accounting firms, consulting firms, investment banks and private capital firms look for compliant ways to automate w

inkl

Read news from The Economist, FT, and more,
with one subscription

Inovio Pharmaceuticals Shareholders Back Board as INO-3107 FDA Review Advances

Inovio Pharmaceuticals (NASDAQ:INO) shareholders approved all proposals presented at the company’s 2026 annual meeting, including the election of eight directors and the ratification of Ernst & Young LLP as the company’s independent registered public accounting firm for the year ending Dec. 31,

Incyte Sets Mid-Year Phase 3 Trial for CALR Antibody 989 as Pipeline Updates Roll Out

Incyte (NASDAQ:INCY) Chief Medical Officer Steven Stein outlined the company’s development priorities across hematology, oncology and immunology, with a particular focus on its mutant CALR antibody 989, during a company news event. Stein said myeloproliferative neoplasms remain “front and center” f

SpaceX Gets the Attention, But These 4 Stocks Could Get the Returns

SpaceX Gets the Attention, But These 4 Stocks Could Get the Returns

InvestorPlace's Luke Lango argues the SpaceX IPO signals a broader AI empire play, naming RDW, HSAI, ARM, and CRWV as his top positioned stocks.

Microsoft Stock Discount May Be Ending as AI Catalysts Build

Microsoft Stock Discount May Be Ending as AI Catalysts Build

Microsoft stock may be nearing the end of its valuation discount as several catalysts and bullish technical signals create new upside potential for MSFT shares.

Apparel Earnings Winners and Losers: Ralph Lauren Takes Off

Apparel Earnings Winners and Losers: Ralph Lauren Takes Off

See why Ralph Lauren saw its largest up-move in over a year after earnings, and the fast-growing apparel stock that analysts are highly bullish on.

LexinFintech Q1 Earnings Call Highlights

LexinFintech (NASDAQ:LX) reported higher first-quarter loan volume and revenue as management said growth in its diversified ecosystem businesses helped offset pressure in online consumer finance amid macroeconomic and industry challenges. On the company’s first-quarter 2026 earnings call, Chairman

The Careful Consumer: What Q1 Earnings Reveal—And Where Cracks May Appear

The Careful Consumer: What Q1 Earnings Reveal—And Where Cracks May Appear

Retail earnings from Walmart, Home Depot, and TJX reveal a cautious consumer facing inflation, debt pressure, and economic uncertainty

Get all your
news in one place.

100's of premium titles.
One news app.

Why Walmart, Target and TJX Got Such Different Reactions After Earnings

Walmart, Target, and TJX Companies all posted strong financial performance in their latest quarters, but only one spiked post-earnings.

Ross Stores Earnings Beat Sends Stock To New Highs

Ross Stores stock hit new highs after a strong earnings beat and raised full-year outlook reinforced the strength of the off-price retail sector.

Voya Financial Grows Earnings Across All 3 Business Segments

Voya Financial combines steady earnings growth, disciplined buybacks, and reliable dividends, though its valuation may limit near-term upside.

IDEAYA Biosciences Eyes Busy 2026 as Darovasertib Advances Toward FDA Filing

IDEAYA Biosciences (NASDAQ:IDYA) Chief Executive Yujiro Hata said the precision oncology company is preparing for a busy 2026, led by regulatory and clinical milestones for darovasertib in metastatic uveal melanoma and multiple data readouts across its pipeline. Speaking at a Stifel-hosted event, H

Get all your
news in one place.

100's of premium titles.
One news app.

InterDigital Eyes $1B ARR by 2030 as 6G, AI Video and Patent Push Take Center Stage

InterDigital (NASDAQ:IDCC) executives outlined the company’s licensing model, growth targets and patent-enforcement strategy during an appearance at the J.P. Morgan TMC conference, emphasizing the company’s role in wireless, video compression and artificial intelligence research. Liren Chen, InterD

IAC Conference Highlights People Inc. Pivot, AI Licensing Upside and MGM Bet

IAC (NASDAQ:IAC) is continuing its transformation from a holding company into People Incorporated, with executives describing the shift as a continuation of a strategy outlined earlier this year that includes asset sales, cost reductions and a sharper focus on People Inc. and MGM Resorts Internation

Horizon Quantum Computing Pte. CEO Says Software Is Key to Quantum's Next Leap

Horizon Quantum Computing Pte. (NASDAQ:HQ) is positioning itself as a software-focused company in the quantum computing sector, aiming to build a hardware-agnostic development environment that can help developers write code for multiple types of quantum computers, Chairman and CEO Dr. Joseph Fitzsim

Honeywell International Nears June 29 Split With 'All Green Lights,' Reaffirms Outlook

Honeywell International (NASDAQ:HON) is on track to complete its planned separation on June 29, the first day of the third quarter, Chief Financial Officer and Senior Vice President Mike Stepniak said at an investor conference. Stepniak said the company is in the “final stages” of separating and de

GSI Technology Bets on Edge AI as APU Projects Point to 2027 Revenue Ramp

GSI Technology (NASDAQ:GSIT) is positioning its associative processing unit, or APU, technology for artificial intelligence workloads at the edge rather than in data centers, Vice President of Sales and Investor Relations Didier Lasserre said during a company presentation. Lasserre, who said he has

The Smart Glasses Gold Rush Is Leaving Old-School Eyewear Behind

Alphabet and Samsung's entry into smart glasses signals a hardware supercycle, challenging Meta's early market lead with EssilorLuxottica.

3 Rare Earth Stocks That Win No Matter What China Does Next

A U.S.-China rare earth truce is active through November 2026 — but China is still throttling shipments. Three domestic producers worth watching now.

1 … 25 26 27 28

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Intel Corporation

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

385,628 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play